Cotización Myovant Sciences Ltd.
Acciones
MYOV
BMG637AM1024
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Director/Board Member | 59 | 22/10/22 |
Nombre | Peso | AuM | Varia. 1 de ene. | Calificación inversor |
---|---|---|---|---|
0.11% | 0 M€ | 0,00 % | - | |
0.08% | 0 M€ | 0,00 % | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,30 % | 46,03 mil M | |
+52,73 % | 44,55 mil M | |
+7,15 % | 40,8 mil M | |
-8,78 % | 28,25 mil M | |
+18,68 % | 27,71 mil M | |
-21,92 % | 18,82 mil M | |
+14,62 % | 13,91 mil M | |
+31,85 % | 12,43 mil M | |
+4,47 % | 10,81 mil M |